Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US Ruchika Sharma12 Dec 2020 4:36 PM ISTAs part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...
USFDA delays decision on Bristol Myers cancer therapy due to COVID-19 travel curbs Ruchika Sharma18 Nov 2020 9:00 AM ISTNew Delhi: Bristol Myers Squibb said on Monday the U.S. health regulator has deferred a decision on an experimental blood cancer therapy that it...
Bristol Myers Squibb posts better than expected Q3 earnings Ruchika Sharma7 Nov 2020 12:09 PM ISTNew Delhi: Bristol Myers Squibb Co on Thursday posted better-than-expected third-quarter earnings, with most of its top-selling drugs outperforming...
Bristol Myers to buy heart drug maker MyoKardia for USD 13 billion Ruchika Sharma8 Oct 2020 12:58 PM ISTBristol Myers said it expects mavacamten to be a " multi-billion dollar asset" and drive significant growth through 2025 and the second half of the...
COVID-19 testing research: Syngene joins global consortium of 19 healthcare organisations Ruchika Sharma3 Oct 2020 12:30 PM ISTNew Delhi: Syngene International Ltd on Thursday said it has joined a global consortium of 19 organisations from the healthcare industry to help...
Dr Reddys settles patent litigation over cancer drug Revlimid with Celgene in US Ruchika Sharma19 Sept 2020 9:45 AM ISTRevlimid is used to treat multiple myeloma and myelodysplastic syndromes.
Indoco Remedies Blood-thinner Apixaban gets USFDA green flag Ruchika Sharma14 Sept 2020 3:02 PM ISTIt is used for patients with health problems caused by a blood clot.
Indoco Remedies Blood-thinner Apixaban gets USFDA green flag Ruchika Sharma14 Sept 2020 3:02 PM ISTIt is used for patients with health problems caused by a blood clot.
Bristol Myers Squibb Onureg gets USFDA approval to treat Acute Myeloid Leukemia Medical Dialogues Bureau12 Sept 2020 9:15 AM ISTPrinceton: Bristol Myers Squibb recently announced that the U.S. Food and Drug Administration (FDA) has approved Onureg (azacitidine 300 mg tablets,...
Bristol Myers Squibb Onureg gets USFDA nod to treat Acute Myeloid Leukemia Ruchika Sharma3 Sept 2020 9:45 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved Onureg® (azacitidine 300 mg...
Bristol Myers, Dragonfly Therapeutics enter global licensing agreement for IL-12 Investigational Immunotherapy Program Ruchika Sharma20 Aug 2020 9:00 AM ISTNew York & Waltham: Bristol Myers Squibb and Dragonfly Therapeutics, Inc., have announced that they have entered into a definitive...
Bristol Myers anticipates recovery in sales of hospital-administered drugs, raises annual profit forecast Ruchika Sharma9 Aug 2020 9:15 AM ISTUS: Bristol Myers Squibb Co (BMY.N) on Thursday raised its annual profit forecast as it predicted a recovery in sales of its...
